X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (5151) 5151
life sciences & biomedicine (4918) 4918
alzheimer's disease (4604) 4604
humans (3270) 3270
neurosciences (3129) 3129
neurosciences & neurology (3102) 3102
animals (2902) 2902
amyloid-β (2592) 2592
amyloid beta-peptides - metabolism (1973) 1973
alzheimer’s disease (1700) 1700
alzheimer disease - metabolism (1470) 1470
mice (1326) 1326
male (1315) 1315
biochemistry & molecular biology (1289) 1289
amyloid β (1163) 1163
alzheimer disease - pathology (1077) 1077
female (931) 931
rats (826) 826
brain - metabolism (727) 727
mice, transgenic (724) 724
disease models, animal (718) 718
aged (670) 670
peptide fragments - metabolism (627) 627
alzheimer disease - genetics (604) 604
amyloid beta-peptides - chemistry (603) 603
amyloid beta-protein precursor - metabolism (593) 593
neurodegenerative diseases (593) 593
cells, cultured (570) 570
neurology (564) 564
cell biology (563) 563
amyloid-β peptide (547) 547
proteins (543) 543
neurons - metabolism (533) 533
pharmacology & pharmacy (524) 524
clinical neurology (521) 521
amyloid β-protein (511) 511
alzheimer disease - drug therapy (508) 508
brain (505) 505
amyloid beta-protein precursor - genetics (499) 499
oxidative stress (494) 494
alzheimer disease (490) 490
amyloid β-peptide (489) 489
brain - pathology (489) 489
tau (483) 483
neurons - drug effects (460) 460
amyloid beta-peptides - toxicity (458) 458
amyloid (456) 456
aged, 80 and over (441) 441
middle aged (435) 435
peptides (432) 432
alzheimers disease (427) 427
neurodegeneration (413) 413
amyloid precursor protein (411) 411
amyloid beta-peptides - pharmacology (389) 389
chemistry (388) 388
pathology (383) 383
physical sciences (380) 380
mice, inbred c57bl (379) 379
dementia (366) 366
apoptosis (353) 353
immunohistochemistry (342) 342
amyloid β protein (337) 337
hippocampus (335) 335
alzheimer disease - physiopathology (333) 333
peptide fragments - chemistry (328) 328
amyloid beta-peptides - genetics (318) 318
biophysics (312) 312
cerebrospinal fluid (312) 312
inflammation (312) 312
cognitive ability (310) 310
neurotoxicity (303) 303
peptide fragments - pharmacology (299) 299
tau proteins - metabolism (296) 296
amyloid β peptide (294) 294
memory (290) 290
peptide fragments - toxicity (289) 289
cell line, tumor (288) 288
phosphorylation (287) 287
tau protein (287) 287
mental disorders (284) 284
amyloid precursor protein secretases - metabolism (280) 280
hippocampus - metabolism (278) 278
microglia (277) 277
dose-response relationship, drug (274) 274
rats, sprague-dawley (269) 269
neuroprotective agents - pharmacology (263) 263
neurons - pathology (262) 262
neuroprotection (262) 262
biomarkers (261) 261
geriatrics & gerontology (254) 254
mutation (252) 252
amyloid‐β (251) 251
amino acid sequence (249) 249
neurons (248) 248
aging (247) 247
cell line (246) 246
pathogenesis (241) 241
amyloid beta-protein (240) 240
amyloid beta-peptides - antagonists & inhibitors (239) 239
analysis (235) 235
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7423) 7423
Japanese (173) 173
Chinese (73) 73
German (14) 14
Korean (14) 14
Portuguese (7) 7
French (4) 4
Spanish (4) 4
Croatian (3) 3
Dutch (3) 3
Russian (3) 3
Norwegian (2) 2
Polish (2) 2
Hungarian (1) 1
Persian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Biological psychiatry (1969), ISSN 0006-3223, 02/2018, Volume 83, Issue 4, pp. 311 - 319
The majority of putative disease-modifying treatments in development for Alzheimer’s disease are directed against the amyloid-β (Aβ) peptide. Among the anti-Aβ... 
Amyloid-β oligomers | Monoclonal antibodies | Amyloid-β | Alzheimer’s disease | Amyloid-related imaging abnormalities | Immunotherapy | Alzheimer's disease | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Psychiatry | Science & Technology | Index Medicus | oligomers
Journal Article
Journal of neurochemistry, ISSN 0022-3042, 07/2009, Volume 110, Issue 2, pp. 697 - 706
One hallmark of Alzheimer disease (AD) is the extracellular deposition of the amyloid β‐peptide (Aβ) in senile plaques. Two major forms of Aβ are produced, 40... 
mass spectrometry | human brain | amyloid β‐peptide variants | quantification | immunohistochemistry | Alzheimer disease | Immunohistochemistry | Human brain | Amyloid β-peptide variants | Quantification | Mass spectrometry
Journal Article
Journal Article
Journal of neurochemistry, ISSN 1471-4159, 12/2006, Volume 101, Issue 4, pp. 1053 - 1059
Neurochemical dementia diagnostics (NDD) can significantly improve the clinically based categorization of patients with early dementia disorders, and the... 
dementias | amyloid β | biomarkers | cerebrospinal fluid | Biomarkers | Cerebrospinal fluid | Dementias | Amyloid β
Journal Article
FEBS letters, ISSN 0014-5793, 01/2019, Volume 593, Issue 1, pp. 128 - 137
The interaction of the amyloid-β peptide (Aβ) with thermolysin (TLN) was investigated by X-ray crystallography. Structural models of the complexes of TLN with... 
X-ray crystallography | β-turn-β conformation | thermolysin inhibition | amyloid-β peptide cleavage | amyloid-β peptide/thermolysin
Journal Article
Alzheimer's & dementia, ISSN 1552-5260, 02/2016, Volume 12, Issue 2, pp. 110 - 120
Abstract Introduction EXPEDITION and EXPEDITION2 were identically designed placebo-controlled phase 3 studies assessing effects of solanezumab, an antiamyloid... 
Neurology | Solanezumab | Cognition | Monoclonal antibody | Amyloid-β peptide | Function | EXPEDITION | Mild Alzheimer's disease | Target engagement | LZAN | Clinical trial | Phase 3 | LZAM | Safety | Amyloid‐β peptide | Severity of Illness Index |